354
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Characterization and expression of extrahepatic CYP2S1

& , PhD
Pages 367-380 | Published online: 15 Apr 2009

Bibliography

  • Rylander T, Neve EP, Ingelman-Sundberg M, Oscarson M. Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem Biophys Res Commun 2001;281:529-35
  • Rivera SP, Saarikoski ST, Hankinson O. Identification of a novel dioxin-inducible cytochrome P450. Mol Pharmacol 2002;61:255-9
  • Negishi M, Uno T, Darden TA, et al. Structural flexibility and functional versatility of mammalian P450 enzymes. FASEB J 1996;10:683-9
  • Hu S, Wang H, Knisely AA, et al. Evolution of the CYP2ABFGST gene cluster in rat, and a fine-scale comparison among rodent and primate species. Genetica 2008;133:215-26
  • Baldwin RM, Shultz MA, Buckpitt AR. Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J Pharmacol Exp Ther 2005;312:857-65
  • Hoffman SM, Nelson DR, Keeney DS. Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19. Pharmacogenetics 2001;11:687-98
  • Imaoka S, Hashizume T, Funae Y. Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. Drug Metab Pharmacokinet 2005;20:478-84
  • Wang H, Donley KM, Keeney DS, Hoffman SM. Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster. Environ Health Perspect 2003;111:1835-42
  • Wang DY, Kumar S, Hedges SB. Divergence time estimates for the early history of animal phyla and the origin of plants, animals and fungi. Proc Biol Sci 1999;266:163-71
  • Bieche I, Narjoz C, Asselah T, et al. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 2007;17:731-42
  • Smith G, Wolf CR, Deeni YY, et al. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 2003;361:1336-43
  • Saarikoski ST, Wikman HA, Smith G, et al. Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. J Histochem Cytochem 2005;53:549-56
  • Downie D, McFadyen MC, Rooney PH, et al. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 2005;11:7369-75
  • Kumarakulasingham M, Rooney PH, Dundas SR, et al. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res 2005;11:3758-65
  • Choudhary D, Jansson I, Schenkman JB, et al. Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 2003;414:91-100
  • Choudhary D, Jansson I, Stoilov I, et al. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch Biochem Biophys 2005;436:50-61
  • Deb S, Bandiera SM. Characterization and regulation of a new cytochrome P450 gene, CYP2S1, in rats [abstract 116]. 14th North American Meeting of International Society for the Study of Xenobiotics. Drug Metab Rev 2006;38S2:70
  • Deb S, Bandiera SM. Tissue distribution of a new cytochrome P450 enzyme, CYP2S1, in rats: effect of aryl hydrocarbon receptor agonists on its expression. American Association of Pharmaceutical Scientists Annual Meeting. AAPS J 2008;10S2
  • Carr BA, Wan J, Hines RN, Yost GS. Characterization of the human lung CYP2F1 gene and identification of a novel lung-specific binding motif. J Biol Chem 2003;278:15473-83
  • Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 2003;43:149-73
  • Zhu LR, Thomas PE, Lu G, et al. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody. Drug Metab Dispos 2006;34:1672-6
  • Arpiainen S, Raffalli-Mathieu F, Lang MA, et al. Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway. Mol Pharmacol 2005;67:1325-33
  • Nagata K, Matsunaga T, Gillette J, et al. Rat testosterone 7 alpha-hydroxylase. Isolation, sequence, and expression of cDNA and its developmental regulation and induction by 3-methylcholanthrene. J Biol Chem 1987;262:2787-93
  • Schmidt JV, Bradfield CA. Ah receptor signaling pathways. Annu Rev Cell Dev Biol 1996;12:55-89
  • Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003;43:309-34
  • Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 2008;21:102-16
  • Wincent E, Amini N, Luecke S, et al. The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans. J Biol Chem 2009;284:2690-6
  • Carlson DB, Perdew GH. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol 2002;16:317-25
  • Rivera SP, Wang F, Saarikoski ST, et al. A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia. J Biol Chem 2007;282:10881-93
  • Girault I, Rougier N, Chesne C, et al. Simultaneous measurement of 23 isoforms from the human cytochrome P450 families 1 to 3 by quantitative reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 2005;33:1803-10
  • Thomas RD, Green MR, Wilson C, et al. Cytochrome P450 expression and metabolic activation of cooked food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in MCF10A breast epithelial cells. Chem Biol Interact 2006;160:204-16
  • Thum T, Erpenbeck VJ, Moeller J, et al. Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 2006;114:1655-61
  • Saarikoski ST, Rivera SP, Hankinson O, Husgafvel-Pursiainen K. CYP2S1: a short review. Toxicol Appl Pharmacol 2005;207:62-9
  • Chan WK, Yao G, Gu YZ, Bradfield CA. Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. J Biol Chem 1999;274:12115-23
  • Lee KA, Burgoon LD, Lamb L, et al. Identification and characterization of genes susceptible to transcriptional cross-talk between the hypoxia and dioxin signaling cascades. Chem Res Toxicol 2006;19:1284-93
  • Hogenesch JB, Chan WK, Jackiw VH, et al. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J Biol Chem 1997;272:8581-93
  • Loudig O, Babichuk C, White J, et al. Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. Mol Endocrinol 2000;14:1483-97
  • Vecchini F, Lenoir-Viale MC, Cathelineau C, et al. Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem Biophys Res Commun 1994;201:1205-12
  • Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996;10:940-54
  • Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997;9:240-6
  • Chen YH, Tukey RH. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J Biol Chem 1996;271:26261-6
  • Morgan ET, Sewer MB, Iber H, et al. Physiological and pathophysiological regulation of cytochrome P450. Drug Metab Dispos 1998;26:1232-40
  • Nebert DW, Puga A, Vasiliou V. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann NY Acad Sci 1993;685:624-40
  • Rowland A, Cutler SN, Yost GS. Retinoic acid regulation of the pulmonary expressed cytochrome P450 2S1 [abstract 1919]. 46th Annual Meeting of Society of Toxicology, 2007
  • Wei YD, Bergander L, Rannug U, Rannug A. Regulation of CYP1A1 transcription via the metabolism of the tryptophan-derived 6-formylindolo[3,2-b]carbazole. Arch Biochem Biophys 2000;383:99-107
  • Wei YD, Helleberg H, Rannug U, Rannug A. Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole. Chem Biol Interact 1998;110:39-55
  • Ray WJ, Bain G, Yao M, Gottlieb DI. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem 1997;272:18702-8
  • White JA, Beckett-Jones B, Guo YD, et al. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem 1997;272:18538-41
  • Smith G, Harty H, McNeilly AD, Wolf CR. Development and characterization of a functional mammalian cell-based expression system for the novel cytochrome P450 2S1 [abstract 49]. 17th International Symposium on Microsomes and Drug Oxidations, 2008;133
  • Wu ZL, Sohl CD, Shimada T, Guengerich FP. Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 2006;69:2007-14
  • Kim DH, Kim KH, Isin EM, et al. Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli. Protein Expr Purif 2008;57:188-200
  • Yun CH, Yim SK, Kim DH, Ahn T. Functional expression of human cytochrome P450 enzymes in Escherichia coli. Curr Drug Metab 2006;7:411-29
  • Stark K, Tang ZM, Salamanca-Pinzon SG, et al. Elucidation of catalytic activities of orphan cytochrome P450 enzymes [abstract 50]. 17th International Symposium on Microsomes and Drug Oxidations, 2008;134
  • Wang SL, He XY, Hong JY. Human cytochrome p450 2s1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine. Drug Metab Dispos 2005;33:336-40
  • Karlgren M, Miura S, Ingelman-Sundberg M. Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 2005;207:57-61
  • Bui P, Hankinson O. Functional characterization of human and mouse cytochrome P450 2S1 proteins using a bacterial recombinant expression system [abstract 1835]. 45th Annual Meeting of Society of Toxicology, 2006
  • Dickmann L, Deeni Y, Smith G, Wolf R. Identification of CYP2S1 ligands [abstract 94]. 14th North American Meeting of International Society for the Study of Xenobiotics. Drug Metab Rev 2006;38S2:56
  • Staskal DF, Diliberto JJ, Devito MJ, Birnbaum LS. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 2005;84:225-31
  • Marill J, Cresteil T, Lanotte M, Chabot GG. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 2000;58:1341-8
  • McSorley LC, Daly AK. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation. Biochem Pharmacol 2000;60:517-26
  • Saarikoski ST, Suitiala T, Holmila R, et al. Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population. Mutat Res 2004;554:267-77
  • Hanzawa Y, Sasaki T, Hiratsuka M, et al. Three novel single nucleotide polymorphisms (SNPs) of CYP2S1 gene in Japanese individuals. Drug Metab Pharmacokinet 2007;22:136-40
  • Jang YJ, Cha EY, Kim WY, et al. CYP2S1 gene polymorphisms in a Korean population. Ther Drug Monit 2007;29:292-8
  • Guengerich FP, Wu ZL, Bartleson CJ. Function of human cytochrome P450s: characterization of the orphans. Biochem Biophys Res Commun 2005;338:465-9
  • Stark K, Guengerich FP. Characterization of orphan human cytochromes P450. Drug Metab Rev 2007;39:627-37
  • Campo-Paysaa F, Marletaz F, Laudet V, Schubert M. Retinoic acid signaling in development: tissue-specific functions and evolutionary origins. Genesis 2008;46:640-56
  • Jimenez-Lara AM, Clarke N, Altucci L, Gronemeyer H. Retinoic-acid-induced apoptosis in leukemia cells. Trends Mol Med 2004;10:508-15
  • Sanz MA, Vellenga E, Rayon C, et al. All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood 2004;104:3490-3
  • Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5
  • Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 2007;116:496-526
  • Ingelman-sundberg M. The role of epigenetics in regulating cytochrome P450 gene expression [abstract 45]. 15th North American Meeting of International Society for the Study of Xenobiotics. Drug Metab Rev 2008;40S3:28
  • Tsuchiya Y, Nakajima M, Takagi S, et al. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 2006;66:9090-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.